Septic shock

General Pharmacology

Volumn 31, Issue 1, 1998, Pages 25-32

  Klosterhalfen, B ^a   Bhardwaj, R S ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Cytokines; Interleukin 10; Septic shock

Indexed keywords

CYTOKINE; ENDOTOXIN; GROWTH FACTOR; HEAT SHOCK PROTEIN; INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

DOG; ENDOTOXEMIA; HUMAN; INFLAMMATION; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVIEW; SEPTIC SHOCK; STRESS;

EID: 0032126564     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(97)00424-2     Document Type: Review

References (108)

1. Abraham E., Wunderink R., Silverman H., Perl T.M., Nasraway S.T., Levy H., Bone R., Wenzel R.P., Balk R., Allred R., Pennington J.E., Wherry J.C. Efficacy and safety of monoclonal antibody to human tumor necrosis factor α in patients with sepsis syndrome. a randomized, controlled, multicenter clinical trial. TNF-α MAb Sepsis Study Group JAMA. 273:1995;934-941.
2. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit. Care Med. 20, 864-874.
3. Ananthan J., Goldberg A.L., Voellmy R. Abnormal proteins serve as eukaryotic stress signals and trigger the activation of heat shock genes. Science. 232:1986;522-524.
4. Astiz M., Saha D., Lustbader D., Lin R., Rackow E. Monocyte response to bacterial toxins, expression of cell surface receptors, and release of anti-inflammatory cytokines during sepsis. J. Lab. Clin. Med. 128:1996;594-600.
5. Baeuerle P.A., Henkel T. Function and activation of NF-kB in the immune system. Annu. Rev. Immunol. 12:1994;141-179.
6. Baker C., Oppenheimer L., Stephans B., Lewis F.R., Trunkey D.D. Epidemiology of trauma deaths. Am. J. Surg. 140:1980;144-150.
7. Barnes P.J., Karin M. Nuclear factor-kB. a pivotal transcription factor in chronic inflammatory diseases N. Engl. J. Med. 336:1997;1066-1071.
8. Beal A.L., Cerra F.B. Multiple organ failure syndrome in the 1990s. systemic inflammatory response and organ dysfunction JAMA. 271(3):1994;226-233.
9. Beutler B., Milsark I.W., Cerami A. Passive immunisation against cachektin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science. 229:1985;869-871.
10. Bone R.C. The pathogenesis of sepsis. Ann. Intern. Med. 115:1991;457-469.
11. Bone R.C. Sir Isaac Newton, sepsis, SIRS and CARS. Crit. Care Med. 24:1996;1125-1128.
12. Cannon J.G., Tompkins R.G., Gelfand J.A., Michie H.R., Stanford G.G., Van Der Meer J.W.M., Endres S., Lonnemann G., Corsetti J., Chernow B., Wilmore D.W., Wolff S.M., Burke J.F., Dinarello C.A. Circulating Interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J. Infect. Dis. 161:1990;79-84.
13. Center for Disease Control Increase in national hospital discharge survey rates for septicemia. United States 1979-87 JAMA. 263:1990;937-938.
14. Chandra R.K. Excessive intake of zinc impairs immune responses. JAMA. 52:1984;1443-1446.
15. Chang S.W., Feddersen C.O., Henson P.M., Voelkel N.F. Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats. J. Clin. Invest. 79(5):1987;1498-1509.
16. Cohen P., Kyriakis J.M., Avruch J. Protein kinase cascades activated by stress and inflammatory cytokines. Bioassays. 18:1996;567-577.
17. Craig E.A. Essential roles of 70kDa heat inducible proteins. Bioassays. 11:1989;48-52.
18. De Maio A. The heat shock response. N. Horizons. 3:1995;198-206.
19. De Waal-Malefyt R., Abrams J., Bennett B., Figdor C.G., De Vries J.E. IL-10 inhibits cytokine synthesis by human monocytes. J. Exp. Med. 174:1991;1209-1220. a.
20. De Waal-Malefyt R., Haanen J., Splits H., Roncarolo M.G., Te Velde A., Figdor C., Johnson K., Kastelein R., Yssel H., De Vries J.E. IL-10 and v-IL-10 strongly reduce antigen specific human T-cell responses by deminishing the antigen presenting capacity of monocytes via downregulation of class II MHC expression. J. Exp. Med. 174:1991;915-924. b.
21. Dinarello C.A. Biology of interleukin 1. FASEB J. 2:1988;108-115.
22. Dinarello C.A., Gelfand J.A., Wolff S.M. Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. JAMA. 269:1993;1829-1835.
23. Dobrowsky R.T., Voyksner R.D., Olson N.C. Effect of SRI 63-675 on hemodynamics and blood PAF levels during porcine endotoxemia. Am. J. Physiol. 260:1991;H1455-H1465.
24. Döcke W.D., Randow F., Syrbe U., Krausch D., Asadullah K., Reinke P., Volk H.D., Kox W. Monocyte deactivation in septic patients. restoration by IFN-gamma treatment Nat. Med. 3:1997;678-681.
25. Doebber T.W., Wu M.S., Robbins J.C., Choy B.M., Chang M.N., Shen T.Y. Platelet-activating factor (Paf) involvement in endotoxin-induced hypotension. studies with PAF receptor antagonist kadsurenone Biochem. Biophys. Res. Commun. 127:1985;799-808.
26. Doughty L., Kaplan S., Carcillo J. The IL-10 response in pediatric sepsis and organ failure. Crit. Care Med. 24(Suppl.):1996;A32.
27. Driessen C., Hirv K., Rink L., Kirchner H. Induction of cytokines by zinc ions in human peripheral blood mononuclear cells and seperated monocytes. Lymphokine Cytokine Res. 13:1994;15-20.
28. Driessen C., Hirv K., Kirchner H., Rink L. Zinc regulates cytokine induction by superantigens and lipopolysaccharide. Immunology. 84:1995;272-277.
29. Ensor J.E., Wiener S.M., McCrea K.A., Viscardi R.M., Crawford E.K., Hasday J.D. Differential effects of hyperthermia on macrophage interleukin-6 and tumor necrosis factor-α expression. Am. J. Physiol. 266:1994;C967-C974.
30. Faist E., Baue A.E., Dittmer H., Heberer G. Multiple organ failure in polytrauma patients. J. Trauma. 23:1983;775-787.
31. Fisher C.J. Jr., Dhainaut J.-F.A., Opal S.M., Pribble J.P., Balk R.A., Slotman G.J., Iberti T.J., Rackow E.C., Shapiro M.J., Greenman R.L., Reines H.D., Shelly M.P., Thompson B.W., LaBrecque J.F., Catalano M.A., Knaus W.A., Sadoff J.C. Recombinant human interleukin-1 receptor antagonist in the treatment of patients with sepsis syndrome. results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1RA Sepsis Syndrome Study Group JAMA. 271:1994;1836-1843.
32. Flohé L., Giertz H. Endotoxins, arachidonic acid and superoxid formation. Urbascheck B. Perspectives on Bacterial Pathogenesis and Host Defense. 1988;123-131 University of Chicago Press, Chicago.
33. Flohé S., Heinrich P.C., Schneider J., Wendel A., Flohe L. Time course of IL-6 and TNF alpha release during endotoxin-induced endotoxin tolerance in rats. Biochem. Pharmacol. 41:1991;1607-1614.
34. Fouqueray B., Philippe C., Amrani A., Perez J., Baud L. Heat shock prevents lipopolysaccharide-induced tumor necrosis factor-synthesis by rat mononuclear phagocytes. Eur. J. Immunol. 22:1992;2983-2987.
35. Fritz H., Jochum M., Daswald K.H., Dittmer H., Kortmann H., Neumann S., Lang H. Granulocyte proteinases as mediators of unspecific proteolysis in inflammation. a review Tschesche H. In Proteinases in Inflammation and Tumor Invasion. 1986;1-23 Walter de Gruyter, Berlin.
36. Glauser M.P., Zanetti G., Baumgartner J.D., Cohen J. Septic shock. pathogenesis Lancet. 338:1992;732-736.
37. Greenman R.L., Schein R.M., Martin M.A., Wenzel R.P., MacIntyre N.R., Emmanuel G., Chmel H., Kohler R.B., McCarthy M., Plouffe J., Russel J.A. A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group. JAMA. 266:1991;1097-1102.
38. Hack C.E., De Groot E.R., Felt-Borsma J.R., Nuijens J.H., Strack van Schijndel R.J.M., Erenberg-Belmer A.J.M., Thijs L.G., Aarden L.A. Increased plasma levels of interleukin-6 in sepsis. Blood. 74:1989;1704-1710.
39. Hall T.J. Role of HSP70 in cytokine production. Experientia. 50:1994;1048-1053.
40. Handley D.A., Van-Valen R.G., Melden M.K., Flury S., Lee M.L., Saunders R.N. Inhibition and reversal of endotoxin-, aggregated IgG- and PAF-induced hypotension in the rat by SRI 63-072, a PAF receptor antagonist. Immunopharmacology. 12:1986;11-16.
41. Hartl F.U. Molecular chaperons in cellular protein folding. Nature. 381:1996;571-580.
42. Hauser G.J., Dayao E.K., Wasserloos K., Pitt B.R., Wong H.R. HSP induction inhibits iNOS mRNA expression and attenuates hypotension in endotoxin-challenged rats. Am. J. Physiol. Heart Circ. Physiol. 40:1996;H2529-H2535.
43. Hinshaw L.B., Beller B.K. Septic shock 1. physiological aspects Hardaway R.M. Shock. The Reversible Stage of Dying:1988;178-185 PSG Publishing, Littleton, MA.
44. Hirvonen M.R., Brüne B., Lapetina E.G. Heat shock proteins and macrophage resistance to the toxic effects of nitric oxide. Biochem. J. 315:1996;845-849.
45. Howard M., Muchamel T., Andrade S., Menon S. Interleukin 10 protects mice from lethal endotoxemia. J. Exp. Med. 177:1993;1205-1208.
46. Hunt C., Morimoto R.I. Conserved features of eukaryotic HSP70 genes revealed by comparison with the nucleotide sequences of human HSP70. Proc. Natl. Acad. Sci. USA. 82:1985;6455-6459.
47. Kilbourn R.G., Szabo C., Traber D.L. Beneficial versus detrimental effects of nitric oxide synthase inhibitors in circulatory shock. lessons learned from experimental and clinical studies Shock. 7:1997;235-246.
48. Klava A., Windsor A.C.J., Farmery S.M., Woodhouse L.F., Reynolds J.V., Ramsden C.W., Boylston A.W., Guillou P.J. Interleukin-10. a role in the development of postoperative immunosuppression Arch. Surg. 132:1997;425-429.
49. Klemenz R., Hultmark D., Gehring W.J. Selective translation of heat shock mRNA in Drosophila melanogaster depends on the sequence information in the leader. EMBO J. 4:1985;2053-2060.
50. Kloostergaard J., Barta M., Tomasovic S.P. Hyperthermic modulation of tumor necrosis factor-dependent monocyte/macrophage tumor cytotoxicity in vitro. J. Biol. Response Modif. 8:1989;262-277.
51. Klosterhalfen B., Hörstmann-Jungemann K., Vogel P., Dufhues G., Simon B., Kalff G., Kirkpatrick C.J., Mittermayer C., Heinrich P.C. Hemodynamic variables and plasma levels of PGI2, TxA2 and IL-6 in a porcine model of recurrent endotoxemia. Circ. Shock. 35:1991;237-244.
52. Klosterhalfen B., Hörstmann-Jungemann K., Vogel P., Flohe S., Offner F., Kirkpatrick C.J., Heinrich P.C. Time course of various inflammatory mediators during recurrent endotoxemia. Biochem. Pharmac. 43:1992;2103-2109.
53. Klosterhalfen B., Töns C., Hauptmann S., Tietze L., Offner F.A., Küpper W., Kirkpatrick C.J. Influence of heat shock protein 70 and metallothionein induction by zinc-bis-(DL-hydrogenaspartate) on the release of inflammatory mediators in a porcine model of recurrent endotoxemia. Biochem. Pharmac. 52:1996;1201-1210.
54. Klosterhalfen B., Hauptmann S., Offner F.A., Amo-Takyi B., Töns C., Winkeltau G., Affify M., Küpper W., Kirkpatrick C.J., Mittermayer C. Induction of heat shock protein 70 by zinc-bis-(DL-hydrogenaspartate) reduces cytokine liberation, apoptosis and mortality rate in a rat model of LD100 endotoxemia. Shock. 7:1997;254-262. a.
55. Klosterhalfen B., Hauptmann S., Tietze L., Töns C., Winkeltau G., Küpper W., Kirkpatrick C.J. The influence of heat shock protein 70 induction on hemodynamic variables in a porcine model of recurrent endotoxemia. Shock. 7:1997;358-363. b.
56. Laszlo A. The relationship of heat-shock proteins, thermotolerance, and protein synthesis. Exp. Cell Res. 178:1988;401-414.
57. Lefer A.M. Significance of lipid mediators in shock states. Circ. Shock. 27:1989;3-12.
58. Lindquist S., Craig E.A. The heat-shock proteins. Annu. Rev. Genet. 22:1988;631-677.
59. Lis J., Wu C. Protein traffic on the heat shock promoter. parking, stalling, and trucking along Cell. 74:1993;1-4.
60. Manship L., McMillan R.D., Brown J.J. The influence of sepsis and multisystem organ failure on mortality in SICU. Ann. Surg. 50:1984;94-101.
61. McCloskey R.V., Straube R.C., Sanders C., Smith S.M., Smith C.R. Treatment of septic shock with human monoclonal antibody HA-1A. a randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group Ann. Intern. Med. 121:1994;1-5.
62. McGarry T.J., Lindquist S. The preferential translation of Drosophila HSP70 mRNA requires sequences in the untranslated leader. Cell. 42:1985;903-911.
63. Morimoto R.I., Sarge K.D., Abravaya K. Transcriptional regulation of heat shock genes. J. Biol. Chem. 267:1992;21987-21990.
64. Movat H.Z., Cybulsky M.I., Colditz I.G., Chan M.K., Dinarello C.A. Acute inflammation in gram-negative infection. endotoxin, interleukin 1, tumor necrosis factor, and neutrophils Fed. Proc. 46:1987;97-104.
65. Neri L.M., Riederer B.M., Marugg R.A., Capitani S., Martelli A.M. Analysis by confocal microscopy of the behavior of heat shock protein 70 within the nucleus and of a nuclear matrix polypeptide during prolonged heat shock response in HeLa cells. Exp. Cell Res. 221:1995;301-310.
66. Nover L. Heat Shock Response of Eukaryotic Cells. 1984;Springer-Verlag, Berlin. pp. 7-10.
67. Nover L. Heat Shock Response. 1991;CRC Press, Boca Raton, FL.
68. Ohlson K., Björk P., Bergenfeldt M., Hagemann R., Thompson R.C. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature. 348:1990;550-552.
69. Parsons P.E., Moss M., Vannice J.L., Moore E.E., Moore F.A., Repine J.E. Circulating IL-1ra and IL-10 levels are increased but do not predict the development of acute respiratory distress syndrome in at-risk patients. Am. J. Respir. Crit. Care Med. 155:1997;1469-1473.
70. Pine R.W., Wertz M.J., Lennard E.S., Dellinger E.P., Carrico C.J., Minshew B.H. Determinants of organ multifunction or death in patients with intra-abdominal sepsis. a discriminant analysis Arch. Surg. 118:1983;243-249.
71. Pinsky M.R., Vincent J.L., Deviere J., Alegre M., Kahn R.J., Dupont E. Serum cytokine levels in human septic shock. relation to multiple-system organ failure and mortality Chest. 103:1993;565-575.
72. Platzer C., Meisel C.H., Vogt K., Patzer M., Volk H.D. Upregulation of monocytic IL-10 by tumor necrosis factor-α and cAMP elevating drugs. Int. Immunol. 7:1995;517-523.
73. Prasad A.S., Fitzgerald J.T., Hess J.W., Kaplan J., Pelen F., Dardenne M. Zinc deficiency in elderly patients. Nutrition. 9:1993;218-224.
74. Rangel-Frausto M.S., Pittet D., Costigan M., Hwang T., Davis C.S., Wenzel R.P. The natural history of the systemic inflammatory response syndrome (Sirs). JAMA. 273:1995;117-123.
75. Riabowol K.T., Mizzen L.A., Welch W.J. Heat shock is lethal to fibroblasts microinjected with antibodies against HSP 70. Science. 242:1988;433-436.
76. Ribeiro S.P., Villar J., DeHoyos A., Slutsky A.S. Heat stress decreases tumor necrosis factor release in LPS-stimulated alveolar macrophages. Am. Rev. Respir. Dis. 147:1993;A229.
77. Ribeiro S.P., Villar J., Downey G., Edelson J.D., Slutsky A.S. Sodium arsenite induces heat shock protein-72 kilodalton expression in the lungs and protects rats against sepsis. Crit. Care Med. 22:1994;922-929. a.
78. Ribiero S.P., Villar J., Li J., Slutsky A.S. Stress response decreases tumor necrosis factor (Tnf) protein levels in septic rats and down regulates TNF gene expression in LPS-stimulated alveolar macrophages. Am. Rev. Respir. Dis. 149:1994;A720. b.
79. Ribiero S.P., Villar J., Downey G.P., Edelson J.D., Slutsky A.S. Effects of the stress response in septic rats and LPS-stimulated alveolar macrophages. evidence for TNF-alpha posttranslational regulation Am. J. Respir. Crit. Care Med. 154:1996;1843-1850.
80. Ritossa F. A new puffing pattern induced by temperature shock and DNP in. Drosophila. Experientia. 21:1962;571-573.
81. Rouse J., Cohen P., Trigon S., Morange M., Alonso-Llamazares A., Zamanillo D., Hunt T., Nebreda A.R. A novel kinase kascade triggered by chemical stress and heat shock which stimulates MAP-kinase-activated protein kinase-2 and phosphorylation of heat shock proteins. Cell. 78:1994;1027-1037.
82. Ryan A.J., Flanagan S.W., Moseley P.L., Gisolfi C.V. Acute heat stress protects rats against endotoxin shock. J. Appl. Physiol. 73:1992;1517-1522.
83. Sadis S., Hickey E., Weber L.A. Effects of heat shock on RNA metabolism in HeLa cells. J. Cell. Physiol. 135:1988;377-386.
84. Samali A., Cotter T.G. Heat shock proteins increase resistance to apoptosis. Exp. Cell Res. 223:1996;163-170.
85. Schlesinger M.J. Heat shock proteins. J. Biol. Chem. 265:1990;12111-12114.
86. Schmidt J.A., Abdulla E. Down-regulation of IL-1 biosynthesis by inducers of the heat shock response. J. Immunol. 141:1988;2027-2034.
87. Singh K.P., Zaidi S.I., Raisuddin S., Saxena A.K., Murthy R.C., Ray P.K. Effect of zinc on immune functions and host resistance against infection and tumor challange. Immunopharmac. Immunotoxicol. 14:1992;813-840.
88. Snedegard G., Lui L., Hugli T.E. Endotoxin induced shock in the rat. a role of C5a Am. J. Pathol. 135:1989;489-497.
89. Snyder Y.M., Guthrie L., Evans G.F., Zuckerman S.H. Transcriptional inhibition of endotoxin-induced monokine synthesis following heat shock in murine peritoneal macrophages. J. Leukocyte Biol. 51:1992;181-187.
90. Sorger P.K. Heat shock factor and the heat shock response. Cell. 65:1991;363-366.
91. Stege G.J.J., Brunsting J.F., Kampinga H.H., Konnings A.W.T. Thermotolerance and nuclear protein aggregation. protection against initial damage or better recovery? J. Cell. Physiol. 164:1995;579-586.
92. Terashita Z., Imura Y., Nishikawa K., Sumida S. Is platelet activating factor (Paf) a mediator of endotoxin shock? Eur. J. Pharmac. 109:1985;257-261.
93. Tissieres A., Mitchell H.K., Tracy U.M. Protein synthesis in salivary glands of Drosophila melanogaster. relation to chromosome puffs J. Mol. Biol. 84:1974;389-398.
94. Traber D.L., Schlag G., Redl H., Strohmair W., Traber L.D. Pulmonary microvascular changes during hyperdynamic sepsis in an ovine model. Circ. Shock. 22:1987;185-193.
95. Trancey K.J., Fong Y., Hesse D.G., Manoque K.R., Lee A.T., Kuo G.C., Lowry S.F., Cerami A. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature. 330:1987;662-664.
96. Van der Poll T., Jansen P.M., Montegut W.J., Braxton C.C., Calvano S.E., Stackpole S.A., Smith S.R., Swanson S.W., Hack C.E., Lowry S.F., Moldawer L.L. Effects of IL-10 on systemic inflammatory responses during sublethal primate endotoxemia. J. Immunol. 158:1997;1971-1975. a.
97. Van der Poll T., Keogh C.V., Buurman W.A., Lowry S.F. Passive immunization against tumor necrosis factor-α impairs host defense during pneumococcal pneumonia in mice. Am. J. Respir. Crit. Care Med. 155:1997;603-608. b.
98. Van der Poll T., Malefyt R.D., Coyle S.M., Lowry S.F. Antiinflammatory cytokine responses during sepsis and experimental endotoxemia. sequential measurements of plasma soluble interleukin (Il)-1 receptor type II, IL-10, and IL-13 J. Infect. Dis. 175:1997;118-122. c.
99. Villar J., Ribeiro S.P., Mullen B.M., Kuliszewski M., Post M., Slutsky A.S. Induction of heat shock response reduces mortality rate and organ damage in a sepsis-induced acute lung injury model. Crit. Care Med. 22:1994;914-921.
100. Volk H.D., Reinke P., Krausch D., Zuckermann H., Asadullah K., Müller J.M., Döcke W.D., Kox W.J. Monocyte deactivation. rationale for a new therapeutic strategy in sepsis Intens. Care Med. 22:1996;S474-S481.
101. Waage A., Halstensen A., Espevik T. Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet. 1:1987;355-357.
102. Waage A., Brandtzaeg P., Halstensen A., Kierulf P., Espevik T. The complex pattern of cytokines in serum of patients with meningococcal septic shock. association between interleukin 6, interleukin 1, and fatal outcome J. Exp. Med. 169:1989;333-338.
103. Warren H.S., Danner R.L., Munford R.S. Antiendotoxin monoclonal antibodies. N. Engl. J. Med. 326:1992;1153-1157.
104. Wenzel R.P., Pinsky M.R., Ulevitch R.J., Young L. Current understanding of sepsis. Clin. Infect. Dis. 22:1996;407-413.
105. West R.L., Elovitz M.J., Hardaway R.M. Blood coagulation factors activity in experimental endotoxemia. Ann. Surg. 163:1966;567-572.
106. Wong H.R., Ryan M., Wispe H.R. The heat shock response inhibits inducible nitric oxide synthase gene expression by blocking Ik-B degradation and NF-kB nuclear translocation. Biochem. Biophys. Res. Commun. 231:1997;257-263.
107. Zalewski P.D., Forbes I.J., Betts W.H. Correlation of apoptosis with change in intracellular labile Zn(II) using Zinquin [(2-methyl-8-p-toluenesulphonamido-6-quinolyloxy)acetic acid], a new specific fluorescent probe for Zn(II). Biochem. J. 296:1993;403-408.
108. Ziegler E.J., Fisher C.J. Jr., Sprung C.I., Straube R.C., Sadoff J.C., Foulke G.E., Wortel C.H., Fink M.P., Dellinger R.P., Teng N.N., Allen I.E., Berger H.J., Knatterud G.L., LoBuglio A.F., Smith C.R. Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. a randomized, double blind, placebo-controlled trial. The HA-1A Sepsis Study Group N. Engl. J. Med. 324:1991;429-436.